Laura Dashner CEO & President and Sandra Serrano Chief Development Officer are presenting “An Interview with Sandra Sapp: The 2018 DOT Changes Impacting Opioid Testing” at 11:15 AM on October 13th in Minneapolis.
The federal DOT regulations expanded the opioid panel to include 4 semi-synthetics on January 1, 2018. The regulations, along with the regulatory guidance, present new challenges for employers, EAPs and SAPs. Join us for a mock interview featuring “Sandra Sapp”, sharing her expert knowledge, training, recommendations and a touch of humor to guide us through a DOT Return-to-Duty SAP process in which the employee tested positive for oxycodone.
SHARE:
ASAP has a nationwide reach in all 50 states and U.S. territories. Our trained and knowledgeable team will assist you in understanding the process and signing up. It’s fast and easy to enroll with ASAP! 888.792.2727 x607
888-792-2727